LHC Net Worth 2006-2020 | LHCG

Interactive chart of historical net worth (market cap) for LHC (LHCG) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. LHC net worth as of September 28, 2020 is $6.55B.
Sector Industry Market Cap Revenue
Medical Medical Services $6.553B $2.080B
LHC Group Inc. is a provider of in-home healthcare services. The company's service covers healthcare needs for patients and families dealing with illness, injury or chronic conditions. LHC Group Inc., formerly known as LHC Group LLC, is based in Lafayette, United States.
Stock Name Country Market Cap PE Ratio
Teladoc Health (TDOC) United States $17.843B 0.00
BIOMERIEUX (BMXMF) France $17.713B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.670B 0.00
Avantor (AVTR) United States $12.857B 31.86
PPD (PPD) United States $11.992B 0.00
Charles River Laboratories (CRL) United States $11.099B 31.38
NovoCure (NVCR) Jersey $10.950B 902.67
ICON (ICLR) Ireland $9.976B 28.75
Amplifon S.p.A (AMFPF) Italy $7.471B 46.48
PRA Health Sciences (PRAH) United States $6.342B 23.78
Natera (NTRA) United States $5.596B 0.00
GETINGE AB (GNGBY) Sweden $5.375B 25.79
Premier (PINC) United States $3.969B 13.03
Medpace Holdings (MEDP) United States $3.892B 36.15
HealthEquity (HQY) United States $3.806B 36.68
AMN Healthcare Services Inc (AMN) United States $2.738B 17.77
Progyny (PGNY) United States $2.427B 470.50
UDG HEALTHCARE (UDHCF) Ireland $2.338B 0.00
CareDx (CDNA) United States $1.696B 0.00
BioTelemetry (BEAT) United States $1.533B 24.92
So-Young (SY) China $1.232B 150.88
Surgery Partners (SGRY) United States $1.005B 0.00
Apollo Medical Holdings (AMEH) United States $0.938B 28.27
Healthways (TVTY) United States $0.681B 9.17
Establishment Labs Holdings (ESTA) $0.436B 0.00
China Cord Blood (CO) China $0.412B 5.95
Co-Diagnostics (CODX) United States $0.399B 78.89
Constellation Alpha Capital (DMTK) United States $0.206B 0.00
RTI Surgical (SRGA) United States $0.152B 0.00
Imprimis Pharmaceuticals (HROW) United States $0.148B 0.00
XpresSpa (XSPA) United States $0.136B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.100B 0.00
Biocept (BIOC) United States $0.058B 0.00
OpGen (OPGN) United States $0.044B 0.00
Interpace Diagnostics (IDXG) United States $0.013B 0.00
Cancer Genetics (CGIX) United States $0.010B 0.00
New Frontier (NFH) China $0.000B 0.00